Related Experiment Video
Updated: Aug 6, 2026
04:27
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Methylprednisolone therapy in a child with unresolving ARDS
Lokesh Guglani1, Siddharth Jain, Rakesh Lodha
1Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110 029, India.
Indian Pediatrics
|August 8, 2006
Summary
Methylprednisolone successfully treated a pediatric patient with severe acute respiratory distress syndrome (ARDS) unresponsive to standard care. The child recovered, was extubated, and weaned off oxygen, demonstrating the drug's safety and efficacy.
Area of Science:
- Pediatric critical care medicine
- Pulmonology
- Pharmacology
Background:
- Acute Respiratory Distress Syndrome (ARDS) in children can be life-threatening and challenging to manage.
- Conventional therapies for pediatric ARDS may not always be effective, necessitating alternative treatment strategies.
Observation:
- A 21-month-old child presented with severe ARDS that showed no improvement with standard treatment protocols.
- The clinical condition of the child necessitated exploration of advanced therapeutic options.
Findings:
- Administration of methylprednisolone resulted in significant clinical improvement in the pediatric patient.
- The child was successfully extubated after 10 days of methylprednisolone treatment and subsequently weaned off supplemental oxygen.
Implications:
- Methylprednisolone demonstrates potential as a safe and effective therapeutic agent for pediatric patients with unresolving ARDS.
- This case highlights the potential benefit of corticosteroids in managing refractory pediatric ARDS, warranting further investigation.
Related Concept Videos
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:17Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...